These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2517020)

  • 1. Magnetic resonance imaging evaluation of learning difficulties and incoordination in neurofibromatosis.
    Dunn DW; Roos KL
    Neurofibromatosis; 1989; 2(1):1-5. PubMed ID: 2517020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Encephalic lesions in neurofibromatosis: clinical manifestations and typical magnetic resonance findings].
    Magnaldi S; White RM; Bryan RN
    Radiol Med; 1990 Dec; 80(6):796-807. PubMed ID: 2126389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Learning problems in neurofibromatosis patients.
    Stine SB; Adams WV
    Clin Orthop Relat Res; 1989 Aug; (245):43-8. PubMed ID: 2502350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neurofibromatosis in children. Our experience].
    López-Pisón J; Cuadrado-Martín M; Boldova-Aguar MC; Muñoz-Mellado A; Cabrerizo de Diago R; Peña-Segura JL
    Rev Neurol; 2003 Nov 1-15; 37(9):820-5. PubMed ID: 14606048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of neurofibromatosis type 1 on school performance.
    Krab LC; Aarsen FK; de Goede-Bolder A; Catsman-Berrevoets CE; Arts WF; Moll HA; Elgersma Y
    J Child Neurol; 2008 Sep; 23(9):1002-10. PubMed ID: 18827266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pilot study of a novel computerized task to assess spatial learning in children and adolescents with neurofibromatosis type 1.
    Ullrich NJ; Ayr L; Leaffer E; Irons MB; Rey-Casserly C
    J Child Neurol; 2010 Oct; 25(10):1195-202. PubMed ID: 20139412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Specific learning and cognitive deficits in neurofibromatosis type 1].
    Mahajnah M; Zimmerman S; Weitz R
    Harefuah; 2001 Apr; 140(4):334-6. PubMed ID: 11303400
    [No Abstract]   [Full Text] [Related]  

  • 8. Development of MRI T2 hyperintensities and cognitive functioning in patients with neurofibromatosis type 1.
    Feldmann R; Schuierer G; Wessel A; Neveling N; Weglage J
    Acta Paediatr; 2010 Nov; 99(11):1657-60. PubMed ID: 21039823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain magnetic resonance imaging of siblings from families with two or more children with learning or intellectual disabilities and need for full-time special education.
    Mannerkoski M; Heiskala H; Raininko R; Aberg L; Sarna S; Wirtavuori K; Autti T
    Acta Radiol; 2009 May; 50(4):437-45. PubMed ID: 19267273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurofibromatosis: implications for learning and behavior.
    Eliason MJ
    J Dev Behav Pediatr; 1986 Jun; 7(3):175-9. PubMed ID: 3088045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydrocephalus in neurofibromatosis. Contribution of magnetic resonance imaging to its diagnosis, control and treatment.
    Pou-Serradell A; Ugarte-Elola AC
    Neurofibromatosis; 1989; 2(4):218-26. PubMed ID: 2517815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MRI and nonverbal cognitive deficits in children with neurofibromatosis 1.
    Bawden H; Dooley J; Buckley D; Camfield P; Gordon K; Riding M; Llewellyn G
    J Clin Exp Neuropsychol; 1996 Dec; 18(6):784-92. PubMed ID: 9157104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 'Moya' than meets the eye: neurofibromatosis type 1 associated with Moyamoya syndrome.
    Tan RM; Chng SM; Seow WT; Wong J; Lim CC
    Singapore Med J; 2008 Apr; 49(4):e107-9. PubMed ID: 18418511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic resonance imaging and behavioral analysis of immature rats with kaolin-induced hydrocephalus: pre- and postshunting observations.
    Del Bigio MR; Crook CR; Buist R
    Exp Neurol; 1997 Nov; 148(1):256-64. PubMed ID: 9398467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain morphometry, T2-weighted hyperintensities, and IQ in children with neurofibromatosis type 1.
    Greenwood RS; Tupler LA; Whitt JK; Buu A; Dombeck CB; Harp AG; Payne ME; Eastwood JD; Krishnan KR; MacFall JR
    Arch Neurol; 2005 Dec; 62(12):1904-8. PubMed ID: 16344348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between T2-weighted hyperintensities (unidentified bright objects) and lower IQs in children with neurofibromatosis-1.
    Denckla MB; Hofman K; Mazzocco MM; Melhem E; Reiss AL; Bryan RN; Harris EL; Lee J; Cox CS; Schuerholz LJ
    Am J Med Genet; 1996 Feb; 67(1):98-102. PubMed ID: 8678124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics of children with cerebral white matter abnormalities.
    Kristjánsdóttir R; Uvebrant P; Wiklund LM
    Eur J Paediatr Neurol; 2000; 4(1):17-26. PubMed ID: 10701100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurological complications involving the central nervous system in neurofibromatosis type 1.
    Hsieh HY; Wu T; Wang CJ; Chin SC; Chen YR
    Acta Neurol Taiwan; 2007 Jun; 16(2):68-73. PubMed ID: 17685129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffusion-weighted MR of the brain: methodology and clinical application.
    Mascalchi M; Filippi M; Floris R; Fonda C; Gasparotti R; Villari N
    Radiol Med; 2005 Mar; 109(3):155-97. PubMed ID: 15775887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A longitudinal magnetic resonance imaging study of the brain in survivors in childhood acute lymphoblastic leukemia.
    Harila-Saari AH; Pääkkö EL; Vainionpää LK; Pyhtinen J; Lanning BM
    Cancer; 1998 Dec; 83(12):2608-17. PubMed ID: 9874469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.